Clinical Trial Update: To Evaluate the Efficacy and Safety of Wenxin Keli in Treating Atrial Premature Beats [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of Wenxin Keli for treating atrial premature beats.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Premature Beats

Drugs mentioned

• Wenxin Keli (Wenxin Keli)

Snippet

Sponsor: Beijing Bozhiyin T&S Co., Ltd. | Conditions: Atrial Premature Beats | Phase 4 | Status: UNKNOWN